Stockscreener 앱 받기
6.13
7.92%
0.45
Treace Medical Concepts Inc 주식(TMCI)의 최신 뉴스
UBS Group Cuts Treace Medical Concepts (NASDAQ:TMCI) Price Target to $6.50 - MarketBeat
Arcadia Wealth Management Inc. Invests $1.76 Million in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported, And Analysts Assigned A US$8.35 Price Target - simplywall.st
Treace Medical anticipates 7–10% revenue growth in 2025 while launching next-gen bunion solutions - MSN
Why did TMCI's Q4 2024 EPS surprise investors? - AInvest
Health Check: How Prudently Does Treace Medical Concepts (NASDAQ:TMCI) Use Debt? - simplywall.st
Stifel Nicolaus Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $6.00 - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q2 2025 Earnings Call Transcript - Insider Monkey
Treace Medical Concepts Maintains Buy Rating with $12 Price Target: Analyst - AInvest
Treace Medical Concepts Inc (TMCI) Q2 2025 Earnings Call Highlights: Revenue Growth and ... By GuruFocus - Investing.com Canada
Treace Medical Concepts revenue up 7% to USD 47.4M in Q2 2025 - Medical Buyer
Treace Medical Concepts Reports Q2 2025 Financial Results - TipRanks
Treace Medical Concepts Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Treace Medical (TMCI) Q2 Revenue Up 7% - The Motley Fool
Treace Medical Concepts Trims Losses As Revenue Rises - Finimize
Treace Medical Concepts, Inc. shares rise 3.35% after-hours after Q2 revenue beats estimates. - AInvest
Treace Medical Concepts: Q2 Earnings Snapshot - San Antonio Express-News
Treace Medical Concepts (TMCI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Treace Medical Concepts Reports Second Quarter 2025 Financial Results - The Manila Times
Earnings: Treace Medical Expands Bunion Surgery Portfolio as Q2 Revenue Grows 7%, EBITDA Loss Shrinks 58% - Stock Titan
Treace Medical to Showcase Revolutionary Bunion Surgery Innovations at Upcoming Investor Day - Stock Titan
Important Notice to Long-Term Shareholders of Centene - GlobeNewswire
Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study - The Manila Times
Revolutionary Bunion Surgery Success: New 4-Year Study Reveals 99.2% Non-Recurrence Rate for Lapiplasty - Stock Titan
GSA Capital Partners LLP Buys Shares of 66,790 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Analyzing Treace Medical Concepts Inc. with risk reward ratio chartsStock Market Watch with Smart Filters - Newser
Is Treace Medical Concepts Inc. stock ready for a breakoutRSI and MACD Signal Summary with Trends - Newser
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.52 Average PT from Analysts - MarketBeat
How to interpret RSI for Treace Medical Concepts Inc. stockConservative Equity Setup with Signal Analysis - Newser
What catalysts could drive Treace Medical Concepts Inc. stock higher in 2025Invest like a pro with expert recommendations - Jammu Links News
What drives Treace Medical Concepts Inc. stock priceUnlock powerful trading techniques - Jammu Links News
What is the risk reward ratio of investing in Treace Medical Concepts Inc. stockUnmatched market performance - Jammu Links News
How many analysts rate Treace Medical Concepts Inc. as a “Buy”Exceptional profit potential - Jammu Links News
Is Treace Medical Concepts Inc. a growth stock or a value stockFree Risk Assessment Services - Jammu Links News
Does Treace Medical Concepts Inc. stock perform well during market downturnsAchieve breakthrough performance with smart picks - Jammu Links News
Treace Medical Concepts (TMCI) to Release Earnings on Thursday - MarketBeat
What makes Treace Medical Concepts Inc. stock price move sharplyMaximize your portfolio’s earning power - Jammu Links News
What institutional investors are buying Treace Medical Concepts Inc. stockTremendous wealth creation - Jammu Links News
Is Treace Medical Concepts Inc. stock overvalued or undervaluedGet expert analysis on top stock picks - Jammu Links News
Is it the right time to buy Treace Medical Concepts Inc. stockUnlock exclusive stock market insights - Jammu Links News
Treace Medical Concepts Inc. Stock Analysis and ForecastInvest smarter with expert stock recommendations - Jammu Links News
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Rating of “Hold” by Brokerages - Defense World
What are Treace Medical Concepts Inc. company’s key revenue driversValue Investing Entry Points With Proven Results - Jammu Links News
Treace Medical Concepts (TMCI) to Release Quarterly Earnings on Thursday - Defense World
Why Treace Medical Concepts Inc. stock attracts strong analyst attentionAI Powered High Return Stock Calls Dominate Watchlists - beatles.ru
Historical volatility pattern of Treace Medical Concepts Inc. visualizedFree Trend Analysis for Safer Trades - Newser
Risk vs reward if holding onto Treace Medical Concepts Inc.Free Reversal Alert Based on RSI Indicator - Newser
Treace Medical Concepts Inc. Tests 50 Day MA After Sharp DeclineRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Institutional Tools Highlight Unusual Flow in Treace Medical Concepts Inc.Watchlist for Low Risk High Return Stocks Updated - metal.it
1.17%
자본화:
|
볼륨(24시간):